Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2- restricted cytotoxic T-cell response

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 4919-4926

  Pique, Claudine ^a   Connan, Francine ^b   Levilain, Jean Pierre ^a   Choppin, Jeannine ^b   Dokhélar, Marie Christine ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; HLA A2 ANTIGEN; RNA POLYMERASE; VIRUS PROTEIN;

ARTICLE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

EID: 0029955710     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.4919-4926.1996     Document Type: Article

References (49)

1. Baba, E., M. Nakamura, K. Ohkuma, J. Kira, Y. Tanaka, S. Nakano, and Y. Niho, 1995. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies. J. Immunol. 154:399-412.
2. Baba, E., M. Nakamura, Y. Tanaka, M. Kuroki, Y. Itoyama, S. Nakano, and Y. Niho. 1993. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type I (HTLV-I) identified by human monoclonal antibodies. J. Immunol. 151:1013-1024.
3. Bangham, C. R. M., S. Daenke, R. E. Phillips, J. K. Cruickshank, and J. I. Bell. 1988. Enzymatic amplification of exogenous and endogenous retroviral sequences from DNA of patients with tropical spastic paraparcsis. EMBO J. 7:4179-4184.
4. Bastian, I., J. Gardner, D. Webb, and I. Gardner. 1993. Isolation of a human T-lymphotropic virus type I strain from Australian aboriginals. J. Virol. 67:843-851.
5. Ciminale, V., G. N. Pavlakis, D. Derse, C. P. Cunningham, and B. K. Felber. 1992. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I. J. Virol. 66:1737-1745.
6. Connan, F., F. Hlavac, J. Hoebeke, J. G. Guillet, and J. Choppin. 1994 Specific assembly of HLA-A2 and HLA-B51 molecules detected by a simple assay: application to the optimisation of HLA-peptide interactions. Eur. J. Immunol. 24:777-780.
7. Daenke, S., A. G. Kermode, S. E. Hall, G. Taylor, J. Weber, S. Nightingale, and C. R. M. Bangham. 1996. High activated and memory eytotoxic T-cell responses to HTLV-I in healthy carriers and patients with tropical spastic paraparesis. Virology 217:139-146.
8. Delamarre, L., C Pique, D. Pham, T. Tursz, and M. C. Dokhélar. 1994. Identification of functional regions in the HTLV-I SU glycoprotein. J. Virol. 68:3544-3549.
9. Delaporte, E., N. Monplaisir, J. Louwagie, M. Peeters, Y. Martin-Prével, J. P. Louis, A. Trebucq, L, Bedjabga, S, Ossari, C. Honoré, B. Larouzé, L. d'Auriol, G. Van Der Groen, and P. Piot. 1991. Prevalence of HTLV-1 and HTLV-II infection in Gabon, Africa: comparison of the serological and PCR results. Int. J. Cancer 49:373-376.
10. Elovaara, I., S. Koenig, A. Y. Brewah, R. M. Woods, T. Lehky, and S. Jacobson. 1993. High human T cell lymphotropic virus type I (HTLV-I)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-I-associated neurological disease. J. Exp. Med. 177:1567-1573.
11. Engelhard, V. H. 1994. Structure of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6:13-23.
12. Falk, K., O. Rötzschke, K. Dered, J. Metzger, G. Jung, and H. Rammensee. 1991. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allcle-specific T cell epitopc forecast. J. Exp. Med. 174:425-434.
13. Falk, K., O. Rôtzschke, S. Stevanovic, G. Jung, and H. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides cluted from MHC molecules. Nature (London) 351:290-296.
14. Franchini, G., F. Wong-Staal, and R. C. Gallo. 1904. Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia. Proc. Natl. Acad. Sci. USA 81:6207-6211.
15. Garry, F. G. 1994, New evidence for involvement of retroviruses in Sjögren's syndrome and other autoimmune diseases. Arthritis Rheum. 37:465-469.
16. Gessain, A., E. Boeri, R. Yanagihara, R. C. gallo, and G. Franchini. 1993. Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from Melanesia: genetic and phylogenetic relationship to HILV-I strains from other geographical regions. J. Virol. 67:1015-1023.
17. Gessain, A., A. Louie. O. Gout, R. C. Gallo, and G. Franchini. 1991. Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh periphcral blood mononuclear cells from patients with tropical spastic paraparesis/ HTLV-I associated myelopathy. J. Virol. 65:1628-1633.
18. Gout, O., M. Baulac, A. Gessain, F. Semah, F. Saal, J. Périés, C. Cabrol, C. Foucault-Fretz, D. Laplane, and F. Sigaux. 1990. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N. Engl. J. Med. 322:383-388.
19. Hall, W. W. 1995. Human T cell lymphotropic virus type 1 and cutaneous leukemia/lymphoma. J. Exp. Med. 180:1581-1585.
20. Hunt, D. F., R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. L. Cox, E. Appella, and V. H. Engelhard. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261-1263.
21. Hunter, E., and R. Swanstrom. 1990. Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157:187-253.
22. Ito, Y. 1985. The epidemiology of human T-cell leukemia/lymphoma virus. Curr. Top. Microbiol. Immunol. 115:99-112.
23. Itoyama, V., S. Minato, J. Kira, I. Goto, H. Sato, K. Okochi, and N. Yamamoto. 1988. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology 38:1302-1307.
24. Jacobson, S., H. Shida, D. E. McFarlin, A. S. Fauci, and S. Koenig. 1990. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (London) 348: 245-248.
25. Kannagi, M., S. Harada, I. Maruyama, H. Inoko, H. Igarashi, G. Kuwashima, S. Sato, M. Monta, M. Kidokoro, M. Sugimoto, S. Funahashi, M. Osame, and H. Shida. 1991. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CDS+ cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol. 8:761-767.
26. Kannagi, M., H. Shida, H. Igarashi, K. Kuruma, H. Murai, Y. Aono, I. Maruyama, M. Osame, T. Hattori, H. Inoko, and S. Harada. 1992. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J. Virol. 66:2928-2933.
27. Kast, W. M., R. M. P. Brandt, J. Sidney, J. Drijfhout, R. T. Kubo, H. M. Grey, C. J. M. Melief, and A. Settt. 1994. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 152:3904-3911.
28. Kinoshita, T., M. Shimoyama, K. Tobinai, M. Ito, S. I. Ito, S. Ikeda, K. Tajima, K. Shimotohno, and T. Sugimura. 1989. Detection of mRNA for the taxl/rexl gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86:5620-5624.
29. Koralnik, I. J., A. Gessain, Z. Berneman, M. Klotman, and G. Franchini. 1992. Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. Proc. Natl. Acad. Sci. USA 89:8813-8817.
30. Kubo, R. T., A. Sett, H. M. Grey, E. Appella, K. Sakaguchi, N. Zhu, D. Arnott, N. Sherman, J. Shabanowitz, H. Michel, W. M. Bodnar, T. A. Davis, and D. F. Hunt. 1994. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152:3913-3924.
31. Kuroki, M., M. Nakamura, Y. Itoyama, Y. Tanaka, H. Shiraki, E. Baba, T. Esaki, T. Tatsumoto, S. Nagafuchi, S. Nakano, and Y. Niho. 1992. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type I. J. Immunol. 149:940-948.
32. Miller, G. J., S. M. Pegram, R. Kirkwood, G. L. A. Beckles, N. T. A. Byam, S. A. Clayden, L. J. Kinley, L. C. Chan, D. C. Carson, and M. F. Greaves. 1986. Ethnic composition, age and sex, together with location and standard of housing as determinants of HTLV-I infection in an urban Trinidadian community. Int. J. Cancer 38:801-808.
33. Murphy, E. L., B. Hanchard, J. P. Figueroa, W. N. Gibbs, W. S. Lofters, M. Campbell, J. J. Goedert, and W. A. Blattner. 1989. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int. J. Cancer 43:250-253.
34. Nam, S. H., M. Kidokoro, H. Shida, and M. Hatanaka. 1988. Processing of gag precursor polyprotein of human T-cell leukemia virus type I by virus-encoded protease. J. Virol. 62:3718-3728.
35. Nijman, H. W., J. G. A. Houbiers, M. P. M. Vierboom, S. H. van der Burg, J. W. Drijfhout, J. D'Amaro, P. Kenemans, C. J. M. Melief, and W. M. Kast. 1993. Identification of peptide sequences that potentially trigger HLA-A2. 1-restricted cytotoxic T lymphocytes. Eur. J. Immunol. 23:1215-1219.
36. Parker, C. E., S. Daenke, S. Nightingale, and C. R. M. Bangham. 1992. Activated, HTLV-I-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 188:628-636.
37. Parker, C. E., S. Nightingale, G. Taylor, J. Weber, and C. R. M. Bangham. 1994. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J. Virol. 68:2860-2868.
38. Parker, K. C., M. A. Bednarek, L. K. Hull, U. Utz, B. Cunningham, H. J. Zweerink, W. E. Biddison, and J. E. Coligan. 1992. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J. Immunol. 149:3580-3587.
39. Pique, C., T. Tursz, and M. C. Dokhélar. 1990. Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: a basis for envelope conservation? EMBO J. 9:4243-4248.
40. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
41. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929-937.
42. Salter, R. D., and P. Creswell. 1986. Impaired assembly and transport of HLA-A and -B antigens in a mutant TXB cell hybrid. EMBO J. 5:943-947.
43. Schulz, T. F., M. L. Calabro, J. G. Hoad, C. V. F. Carrington, E. Matutes, D. Catovsky, and R. A. Weiss. 1991. HTLV-I envelope sequences from Brazil, the Caribbean, and Romania: clustering of sequences according to geographic origin and variability in an antibody epitope. Virology 184:483-491.
44. Seiki, M., S. Hattori, V. Hirayama, and M. Yoshida. 1983. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. USA 80:3618-3622.
45. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. M. Melief, C. Oseroff, L. Yuan, J. Ruppert, J. Sidney, M. del Guercio, S. Southwood, R. T. Kubo, R. W. Chesnut, H. M. Grey, and F. V. Chisari. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586-5592.
46. Tajima, K., and S. Tominaga. 1985. Epidemiology of adult T-cell leukemia/lymphoma in Japan. Curr. Top. Microbiol. Immunol. 115:53-66.
47. Tanaka, Y., R. Tanaka, E. Terada, Y. Koyanagi, N. Miyano-Kurosaki, N. Yamamoto, E. Baba, M. Nakamura, and H. Shida. 1994. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. J. Virol. 68:6323-6331.
48. Tsomides, T., A, Aldovini. R. P. Johnson, B. D. Walker, A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283-1293.
49. Yoshida, M., M. Seiki, K. Yamaguchi, and K. Takatsuki. 1984. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc. Natl. Acad. Sci. USA 81:2534-2537.